Benjamin J. Thompson

1.8k citations

22 papers · 1.3k indexed · h-index 11

Hematology top 5%
Molecular Biology top 10%
- Fibroblast Growth Factor Research 3
- Ubiquitin and proteasome pathways 3
Cancer Research top 10%
Aging top 10%
Immunology top 10%
- Immunotherapy and Immune Responses 3
Cell Biology
- Proteoglycans and glycosaminoglycans research 4
Oncology
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
Public Health, Environmental and Occupational Health
- Down syndrome and intellectual disability research 2
Pharmacology
- Microbial Natural Products and Biosynthesis 2

Co-authors: Iannis Aifantis Silvia Buonamici Teresa Palomero Adolfo A. Ferrando Tomas Vilimas Giuseppe Basso Maria Luisa Sulis Jiří Zavadil
Cited by: Hematology Molecular Biology Cancer Research
Partner nations: United States United Kingdom France

In The Last Decade

Benjamin J. Thompson

21 papers receiving 1.3k citations

Peers

Countries citing papers authored by Benjamin J. Thompson

Since Specialization

Citations

This map shows the geographic impact of Benjamin J. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Thompson more than expected).

Fields of papers citing papers by Benjamin J. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Thompson. The network helps show where Benjamin J. Thompson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Benjamin J. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin J. Thompson Line = papers co-authored together Benjamin J. Thompson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors Manojkumar Bupathi,Judy S. Wang,Siwen Hu‐Lieskovan,Sarina A. Piha‐Paul,Bartosz Chmielowski,Benjamin Garmezy,Yana G. Najjar,Mark N. Stein,Li Yao,Jitendra Kanodia,Raphael Clynes,Patricia McGovern,Benjamin J. Thompson	2023	3
2	A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3). Mehmet Akce,Siwen Hu‐Lieskovan,Matthew J. Reilley,James Strauss,Jennifer M. Specht,Mark N. Stein,Judy S. Wang,Jennifer H. Choe,Rom S. Leidner,Diwakar Davar,Gerald S. Falchook,Shubham Pant,Ezra E.W. Cohen,Breelyn A. Wilky,Benjamin J. Thompson,Raphael Clynes,Lingling Li,Patricia McGovern,David Liebowitz	2022	8
3	The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 Chun‐Mei Zhao,Benjamin J. Thompson,Kelly Chen,Feng Gao,Barbara Blouw,Mathieu Marella,Susan Zimmerman,Trevor Kimbler,Sheryl A. Garrovillo,Jesse Bahn,Lei Huang,Zhongdong Huang,H. Michael Shepard,Sanna Rosengren,Christopher D. Thanos,Daniel C. Maneval	2019	7
4	Abstract 1743: Rationale for evaluating PEGylated recombinant human hyaluronidase PH20 (pegvorhyaluronidase alfa; PEGPH20) in patients with hyaluronan (HA)-accumulating colorectal cancer Renee Clift,Benjamin J. Thompson,Darin Taverna,Barbara Blouw,Ji Sook Lee,Curtis B. Thompson,Daniel C. Maneval	2018	1
5	PO-262 Remodelling of the tumour microenvironment by pegvorhyalurondiase alfa (PEGPH20): a novel, first-in-class biologic that enzymatically degrades tumour hyaluronan (HA) to improve anti-tumour efficacy Benjamin J. Thompson,Jae Nam Lee,Renee Clift,Darin Taverna,Sheryl A. Garrovillo,Barbara Blouw,Dong Hyun Kang,Curtis B. Thompson,Daniel C. Maneval	2018	0
6	Abstract B38: Increasing tumor-infiltrating CD8+ T cell response and checkpoint inhibitor efficacy by enzymatic reduction of tumor hyaluronan in a murine syngeneic pancreatic cancer model Benjamin J. Thompson,Trevor Kimbler,Barbara Blouw,Renee Clift,Yujun Huang,Sanna Rosengren,Curtis B. Thompson,Ji‐Sook Lee	2018	2
7	The mitochondrial respiratory chain is essential for haematopoietic stem cell function Elena Ansó,Samuel E. Weinberg,Lauren Diebold,Benjamin J. Thompson,Sébastien Malinge,Paul T. Schumacker,Xin Liu,Yuannyu Zhang,Zhen Shao,Mya Steadman,Kelly Marsh,Jian Xu,John D. Crispino,Navdeep S. Chandel	2017	221
8	Abstract 4886: PEGylated recombinant hyaluronidase PH20 (PEGPH20) enhances checkpoint inhibitor efficacy in syngeneic mouse models of cancer Sanna Rosengren,Renee Clift,Susan Zimmerman,Jennifer Souratha,Benjamin J. Thompson,Barbara Blouw,Xiaoming Li,Qiping Zhao,Michael Shepard,Dan Maneval,Christopher D. Thanos,Curtis B. Thompson	2016	8
9	DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3 Benjamin J. Thompson,Rahul S. Bhansali,Lauren Diebold,Daniel E. Cook,Lindsay R. Stolzenburg,Anne-Sophie Casagrande,Thierry Besson,Bertrand Leblond,Laurent Désiré,Sébastien Malinge,John D. Crispino	2015	50
10	The Chromosome 21 Kinase DYRK1A Controls Cell Cycle Exit and Survival During Lymphoid Development and Is a Novel Therapeutic Target In Acute Lymphoblastic Leukemia Benjamin J. Thompson,Lauren Diebold,Sébastien Malinge,Bertrand Leblond,Anne-Sophie Casagrande,Laurent Désiré,Alicia Foucourt,Thierry Besson,Nobuko Hijiya,John D. Crispino	2013	1
11	Dissecting the complete lipoprotein biogenesis pathway in Streptomyces scabies David A. Widdick,Matthew G. Hicks,Benjamin J. Thompson,Andreas Tschumi,Govind Chandra,Iain C. Sutcliffe,Juliane K. Brülle,Peter Sander,Tracy Palmer,Matthew I. Hutchings	2011	38
12	Investigating lipoprotein biogenesis and function in the model Gram‐positive bacterium Streptomyces coelicolor Benjamin J. Thompson,David A. Widdick,Matthew G. Hicks,Govind Chandra,Iain C. Sutcliffe,Tracy Palmer,Matthew I. Hutchings	2010	54
13	Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase–substrate complex Linsey B. Reavie,Giusy Della Gatta,Kelly M. Crusio,Beatriz Aranda-Orgillés,Shannon M. Buckley,Benjamin J. Thompson,Eugine Lee,Jie Gao,Andrea Bredemeyer,Beth A. Helmink,Jiří Zavadil,Barry P. Sleckman,Teresa Palomero,Adolfo A. Ferrando,Iannis Aifantis	2010	97
14	Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7 Benjamin J. Thompson,Vladimir Janković,Jie Gao,Silvia Buonamici,Alan Vest,Jennifer May Lee,Jiří Zavadil,Stephen D. Nimer,Iannis Aifantis	2008	145
15	Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7 Benjamin J. Thompson,Vladimir Janković,Jie Gao,Silvia Buonamici,Alan Vest,Jennifer May Lee,Jiří Zavadil,Stephen D. Nimer,Iannis Aifantis	2008	2
16	The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia Benjamin J. Thompson,Silvia Buonamici,Maria Luisa Sulis,Teresa Palomero,Tomas Vilimas,Giuseppe Basso,Adolfo A. Ferrando,Iannis Aifantis	2007	363
17	Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia Tomas Vilimas,Joaquina Mascarenhas,Teresa Palomero,Malay Mandal,Silvia Buonamici,Fanyong Meng,Benjamin J. Thompson,Christina Spaulding,Sami Macaroun,Maria‐Luisa Alegre,Barbara L. Kee,Adolfo A. Ferrando,Lucio Miele,Iannis Aifantis	2006	261
18	The Temperature Dependence of the Inositol Monophosphatase K_m Correlates with Accumulation of Di-myo-inositol 1,1‘-Phosphate in Archaeoglobus fulgidus Yanling Karen Wang,Adam J. Morgan,Kimberly A. Stieglitz,Boguslaw Stec,Benjamin J. Thompson,Scott J. Miller,Mary F. Roberts	2006	18
19	Expression proteomics identifies biochemical adaptations and defense responses in transgenic plants with perturbed polyamine metabolism Marina Franceschetti,Barry Perry,Benjamin J. Thompson,Colin Hanfrey,Anthony J. Michael	2004	9
20	Transcription Factor FnrP from Paracoccus denitrificans Contains an Iron-Sulfur Cluster and Is Activated by Anoxia: Identification of Essential Cysteine Residues Matthew I. Hutchings,Jason C. Crack,Neil Shearer,Benjamin J. Thompson,Andrew J. Thomson,Stephen Spiro	2002	22

About Benjamin J. Thompson

Benjamin J. Thompson is a scholar working on Immunology, Hematology and Cell Biology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (4 papers), Fibroblast Growth Factor Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Ubiquitin and proteasome pathways (3 papers), Down syndrome and intellectual disability research (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (301 citations), Molecular Biology (901 citations) and Cancer Research (191 citations). Benjamin J. Thompson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Iannis Aifantis, Silvia Buonamici, Teresa Palomero, Adolfo A. Ferrando, Tomas Vilimas, Giuseppe Basso, Maria Luisa Sulis, Jiří Zavadil, John D. Crispino and Lauren Diebold.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact